Renovos, a regenerative medicine company, is pioneering a nanoclay gel technology platform, RENOVITE^®, at the forefront of innovation for medical applications to address the unmet need for long-term tissue regeneration, offering safer, more economic clinical solutions for health systems, and better outcomes for patients. We develop novel formulations, manufacture and test nanoclay materials to be used in tissue engineering and regenerative medicine applications. Our RENOVITE^® BMP-2 product indicated for spinal fusion has been granted a Breakthrough Device Designation by the FDA. We are increasing our range of R&D projects based on the nanoclay platform, and are looking to start to operate to ISO 13485:2016 medical device quality standards. Our lab is based at the Southampton Science Park and we collaborate closely with the University of Southampton at the General Hospital site. We are looking to recruit exceptional scientists in R&D to take our exciting patented technology forward, wanting to work in an environment that values creativity and discovery.